Research Reports on Idiopathic Pulmonary Fibrosis from Navy Medical University Provide New Insights (Identification of CFH and FHL2 as biomarkers for idiopathic pulmonary fibrosis).
In: Respiratory Therapeutics Week, 2024-05-31, S. 1426-1426
serialPeriodical
Zugriff:
A recent study conducted by Navy Medical University in Shanghai, China, has identified potential biomarkers for idiopathic pulmonary fibrosis (IPF), a fatal lung disease with no known cause or effective treatments. The researchers used bioinformatics analysis and machine learning algorithms to pinpoint specific genes associated with IPF, and further experiments confirmed the diagnostic accuracy of two key genes, CFH and FHL2. These findings may lead to improved understanding of IPF's pathogenesis and the development of therapeutic targets. The study was published in Frontiers in Medicine. [Extracted from the article]
Copyright of Respiratory Therapeutics Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Research Reports on Idiopathic Pulmonary Fibrosis from Navy Medical University Provide New Insights (Identification of CFH and FHL2 as biomarkers for idiopathic pulmonary fibrosis).
|
---|---|
Zeitschrift: | Respiratory Therapeutics Week, 2024-05-31, S. 1426-1426 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6659 (print) |
Schlagwort: |
|
Sonstiges: |
|